Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Electronic Pipette

By Drug Discovery Trends Editor | July 5, 2012

Sartorius, an international process and laboratory technology provider, has launched the Biohit Picus electronic pipette for laboratory professionals.

Biohit Picus is the lightest and smallest electronic pipette currently on the market. Its ergonomic design ensures optimal working posture and allows comfortable handling to ease the workload of laboratory professionals in long pipetting series. Moreover, the light weight design and electronic tip ejection help protect users from repetitive strain injury.

With Biohit Picus laboratory professionals achieve more reliable results. New generation technology – electronic brake and the piston control system – guarantee optimal pipetting results. The electronic brake stops the piston movement rapidly to guarantee accurate and precise pipetting results especially in serial dispensing. The integrated plate tracker further increases reliability in microwell plate work by guiding the user to pipette into correct wells.

The pipette has an intuitive user interface which makes it easy to adopt the main functions even without the help of a manual.  The one-handed adjustment wheel allows easy menu navigation and fast volume setting.  The hot key enables fast access to up to 10 saved programs, easing up routine work.

Biohit Picus received the Red Dot award 2012 in the category product design. The award is one of the most appreciated quality seals for outstanding designs globally.

Sartorius https://www.sartorius.com/


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50